Article
Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in…
eLife · 2023 · Serkan Sayin, author Brittany Rosener, author Carmen G Li, author Bao Ho, author Olga Ponomarova, author Doyle V Ward, author Albertha JM Walhout, author Amir Mitchell, author ([email protected]) Christian R Landry, editor Christian R Landry, senior_editor
Key facts
| Title | Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in co-cultured cancer cells |
|---|---|
| First author | Serkan Sayin, author Brittany Rosener, author Carmen G Li, author Bao Ho, author Olga Ponomarova, author Doyle V Ward, author Albertha JM Walhout, author Amir Mitchell, author ([email protected]) Christian R Landry, editor Christian R Landry, senior_editor |
| Journal | eLife |
| Published | Feb 3, 2023 |
| DOI | 10.7554/eLife.83140 |
| Devices mentioned | K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186, K854187 and 1 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 6 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1